Dosage and protocol evidence
Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.
A single 100 mcg inhaled aviptadil exposure was evaluated with haemodynamic and blood-gas measurements
This was a monitored acute physiology study, not a subcutaneous protocol or an established general treatment schedule.
View sourceAviptadil was infused for 12 hours daily for three days at 600, 1,200 and 1,800 pmol/kg on successive days
This hospital infusion schedule was indication-specific and did not establish benefit for a general or self-directed VIP protocol.
View sourceEvidence summary
A vasoactive neuropeptide studied through intravenous, inhaled and other specialist routes. Rapid haemodynamic effects make route and monitoring central.
Protocol basis
The page groups evidence by route and refuses to collapse monitored infusion or inhalation studies into a single self-directed injection schedule.
What remains uncertain
A general indication, route-equivalent exposure, long-term safety and matched retail formulation remain unestablished.